Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 472 M485 M457 M446 M464 M 1.85 B Research & development 517 M527 M518 M521 M510 M 2.08 B Operating income 1.32 B1.56 B1.66 B1.47 B1.81 B 6.51 B Non-Operating Income, Total 80 M48 M62 M40 M47 M 197 M Interest expense, net of interest capitalized 4 M2 M3 M3 M3 M 11 M Non-Operating Income, excl. Interest Expenses -4 M-2 M-3 M-3 M-3 M -11 M Unusual income/expense 80 M48 M62 M40 M47 M 197 M Pretax income 1.28 B1.48 B1.58 B1.37 B1.71 B 6.15 B Equity in earnings ————— — Taxes 97 M183 M220 M209 M169 M 781 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 1.18 B1.29 B1.36 B1.16 B1.54 B 5.37 B Discontinued operations ————— — Net income 1.18 B1.29 B1.36 B1.16 B1.54 B 5.37 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.17 B1.29 B1.36 B1.16 B1.54 B 5.34 B Basic earnings per share (Basic EPS) 1.291.421.491.271.69 5.87 Diluted earnings per share (Diluted EPS) 1.281.411.481.281.68 5.85 Average basic shares outstanding 910 M908 M909 M909 M909 M — Diluted shares outstanding 916 M912 M914 M913 M914 M — EBITDA 1.75 B2.02 B2.25 B2.01 B2.35 B 8.63 B EBIT 1.32 B1.56 B1.75 B1.47 B1.81 B 6.59 B Cost of revenue 1.76 B1.87 B2.02 B1.95 B2.03 B 7.87 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 424 M460 M497 M537 M541 M 2.04 B